Assesses toxicity of Mitragyna speciosa extracts in zebrafish embryos, indicating important safety thresholds.
has been traditionally used in Southeast Asia to treat various health conditions. This study evaluated the toxicity of leaf extracts obtained using 100% methanol through maceration (100%M) and ultrasonic-assisted (100%U) extractions. The acute toxicity of both extracts was assessed using zebrafish embryos, following OECD 236 guidelines. Both extracts revealed concentration dependent lethality and developmental defects. The 100%M exhibited greater toxicity (LC50 = 247.67 µg/mL) compared to the 100%U (LC50 = 395.26 µg/mL), with more severe impacts on hatchability, eye size, heartbeat and body length. At their lowest tested concentrations (31.25 µg/mL for 100%M and 200 µg/mL for 100%U), both extracts showed no lethal or sub lethal effects, indicating a threshold below which embryonic development remains unaffected. Q ToF LCMS analysis detected luteolin 7 rhamnosyl(1→6)galactoside, 6 hydroxyluteolin 5 rhamnoside, 8 hydroxyluteolin 8 glucoside, reserpic acid, methyl reserpate, 17-O-acetylajmaline and mitragynine which may underlie the toxicological effects associated with kratom leaves.
No takes yet. Share an insight, caveat, or question.
Begum et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: